Published in J Surg Res on May 01, 2003
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res (2006) 1.08
Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist. Tissue Eng (2006) 0.97
Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A (2009) 0.95
Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am (2012) 0.93
Functional evaluation of a new bioartificial liver system in vitro and in vitro. World J Gastroenterol (2006) 0.83
Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. Technology (Singap World Sci) (2015) 0.81
Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology (2006) 0.79
Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. J Mater Sci Mater Med (2011) 0.76
Selectivity of biopolymer membranes using HepG2 cells. Regen Biomater (2015) 0.75
Evaluation of a novel choanoid fluidized bed bioreactor for future bioartificial livers. World J Gastroenterol (2014) 0.75
Microgravity as a means to incorporate HepG2 aggregates in polysaccharide-protein hybrid scaffold. J Mater Sci Mater Med (2015) 0.75
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
A network-based analysis of systemic inflammation in humans. Nature (2005) 12.60
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87
Significance analysis of time course microarray experiments. Proc Natl Acad Sci U S A (2005) 8.65
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A (2010) 7.77
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Circulating tumor cells: approaches to isolation and characterization. J Cell Biol (2011) 6.54
Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol (2002) 5.37
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med (2013) 4.74
Continuous inertial focusing, ordering, and separation of particles in microchannels. Proc Natl Acad Sci U S A (2007) 4.44
Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med (2010) 3.90
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature (2012) 3.40
Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A (2004) 3.30
Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (2013) 3.26
Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics (2004) 3.22
Support of the metabolic response to burn injury. Lancet (2004) 3.06
A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects. Lab Chip (2006) 2.89
Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One (2007) 2.80
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov (2012) 2.76
Effect of flow and surface conditions on human lymphocyte isolation using microfluidic chambers. Langmuir (2004) 2.76
Multifunctional encoded particles for high-throughput biomolecule analysis. Science (2007) 2.75
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Engineering complex tissues. Tissue Eng (2006) 2.53
Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology (2008) 2.50
Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50
Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant (2010) 2.50
Controlled encapsulation of single-cells into monodisperse picolitre drops. Lab Chip (2008) 2.48
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology (2008) 2.45
The Drosophila melanogaster toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa. Infect Immun (2003) 2.41
Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol (2008) 2.32
Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe (2013) 2.29
High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25
MYC regulation of a "poor-prognosis" metastatic cancer cell state. Proc Natl Acad Sci U S A (2010) 2.21
The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med (2012) 2.17
Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15
Equilibrium separation and filtration of particles using differential inertial focusing. Anal Chem (2008) 2.13
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
A microchip approach for practical label-free CD4+ T-cell counting of HIV-infected subjects in resource-poor settings. J Acquir Immune Defic Syndr (2007) 2.08
Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures. Ann Surg (2012) 2.07
Long-term posttraumatic stress symptoms vary inversely with early opiate dosing in children recovering from serious burns: effects durable at 4 years. J Trauma Acute Care Surg (2014) 2.03
Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02
Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal Chem (2004) 2.00
Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94
Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients. Crit Care Med (2013) 1.94
A high-throughput microfluidic real-time gene expression living cell array. Lab Chip (2006) 1.93
Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science (2011) 1.87
Microfluidic system for measuring neutrophil migratory responses to fast switches of chemical gradients. Lab Chip (2005) 1.86
Universal microfluidic gradient generator. Anal Chem (2006) 1.85
Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways. Proc Natl Acad Sci U S A (2006) 1.82
Spontaneous migration of cancer cells under conditions of mechanical confinement. Integr Biol (Camb) (2009) 1.81
The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma (2007) 1.76
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol (2012) 1.74
A microfabrication-based dynamic array cytometer. Anal Chem (2002) 1.74
Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med (2008) 1.67
Morbidity and survival probability in burn patients in modern burn care. Crit Care Med (2015) 1.67
Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng (2009) 1.66
Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc Natl Acad Sci U S A (2010) 1.63
Cell detection and counting through cell lysate impedance spectroscopy in microfluidic devices. Lab Chip (2007) 1.63
Particle segregation and dynamics in confined flows. Phys Rev Lett (2009) 1.62
Human transcriptome array for high-throughput clinical studies. Proc Natl Acad Sci U S A (2011) 1.62
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J (2004) 1.61
Continuous flow microfluidic device for rapid erythrocyte lysis. Anal Chem (2004) 1.61
Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip (2009) 1.61
Polar stimulation and constrained cell migration in microfluidic channels. Lab Chip (2007) 1.60
Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58
Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells (2008) 1.58
Particle focusing in staged inertial microfluidic devices for flow cytometry. Anal Chem (2010) 1.57
Microfluidic diffusive filter for apheresis (leukapheresis). Lab Chip (2005) 1.54
Spatially Invariant Vector Quantization: A pattern matching algorithm for multiple classes of image subject matter including pathology. J Pathol Inform (2011) 1.53
Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal Chem (2006) 1.53
Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A (2008) 1.52
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun (2007) 1.52
Development of a microfabricated cytometry platform for characterization and sorting of individual leukocytes. Lab Chip (2004) 1.52
What's new in burns and metabolism. J Am Coll Surg (2004) 1.51
Dynamic gene expression profiling using a microfabricated living cell array. Anal Chem (2004) 1.50